This week's top two healthcare buys: ResMed Inc and Global Health Limited

Two companies with strong prospects for health-consious investors.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Two quality healthcare companies that have caught my eye this week are ResMed Inc (ASX: RMD) and Global Health Limited (ASX: GLH).

Shares in mask and breathing device maker ResMed Inc have had a hard time this year and are down 17% in the last six months. This has taken some of the shine off the shares and brings them down to a much more appealing buying price.

One reason ResMed shares have been falling is because of slowing sales in the U.S which have spooked investors since the company made the announcement at its half year result in February. However ResMed remains globally diversified and is still recording growth in a number of its other markets.

Another reason for the fall could be the growth witnessed by new, low-tech competitor Somnomed Limited (ASX: SOM). Somnomed provide a mouth-guard type adjuster called SomnoDent to open a patient's airway and prevent obstructive sleep apnea. Over the same period that ResMed's shares have been falling, Somnomed's shares have rocketed 32% supported by a 39% growth in sales.

However the market for sleep apnea solutions is huge, with 10% of 30-70-year-olds suffering from sleep apnea in a moderate to severe form according to ResMed. ResMed also has a thriving masks business which have various additional healthcare uses and make up 46% of total sales.

Global Health Limited (ASX: GLH) is a smaller company with significant growth potential. The company offers cloud-based software services for hospital operators. Global Health announced an outstanding half-year result with revenue up 22% and NPAT up 38% which drove shares up strongly.

However investor enthusiasm has calmed down in the last five trading days and shares have fallen 9% to $0.71. Global Health has the ingredients to become a big growth story in the next few years, combining two of the biggest growth trends around: cloud computing and healthcare spending.

Foolish takeaway

Healthcare stocks are likely to remain among the top growth companies over the next five years due to a favourable cocktail of demographic factors. The recent fall in share price for ResMed and Global Health make them two of the top companies to consider adding to your portfolio this week.

Motley Fool contributor Regan Pearson owns shares in Global Health Limited.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »